Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
But it noted it did not establish a causal relationship
PMID 29239759
Let it be a full experiencenot a sneaky one
In a recent study, researchers investigated whether starting a glucagon-like peptide-1 receptor agonist (GLP-1 RA), like Ozempic or Wegovy, is associated with lower seizure recurrence and related outcomes in adults with both epilepsy and type 2 diabetes
Semaglutide: The Newest Once-Weekly GLP-1 RA for Type 2 Diabetes
US$ 26.45
US$ 28.70
US$ 20.61
